Pathology Technology Australia

Pathology Technology Australia (PTA) is the leading industry body established in 2009, representing manufacturers, importers, and suppliers of diagnostic technologies and tests used in pathology laboratories, hospitals, community clinics, and home testing across Australia. PTA members provide over 90% of the pathology tests and technologies that facilitate more than 500 million pathology tests annually, playing a vital role in the health management of Australians. PTA advocates for its members in government consultations and regulatory frameworks, ensuring access to advanced diagnostic tools. The organization offers market data, professional development, and networking opportunities, while also supporting the development of local manufacturing capabilities in the health technology sector. PTA collaborates with clinical and research institutes to advance diagnostic applications and therapies, contributing to innovations like CAR-T therapy for blood cancers. The technologies supplied by PTA members are essential for a wide range of in vitro diagnostic tests, including those for infectious diseases and genetic markers. These tools enhance clinical decision-making and improve patient outcomes, addressing the challenges of an aging population and chronic disease management in Australia.

• Employees 12
• Founded 2009